Combination of gemcitabine and cisplatin in advanced non-small cell lung cancer
A prospectively designed phase II study of non-small cell lung cancer stage IIIb and IV treated by gemcitabine and cisplatin was studied. The dosage of gemcitabine was lg/m2 weekly on day 1, 8 and 15. Cisplatin 100 mg/m2 was given on day 15 of each 28 day cycle. Twenty-eight patients were treated an...
Saved in:
Main Authors: | Thongprasert S., Chewaskulyong B., Pothirat C. |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-0034849569&partnerID=40&md5=b3a2dbd695d69b2add961e0a458f9817 http://www.ncbi.nlm.nih.gov/pubmed/11460942 http://cmuir.cmu.ac.th/handle/6653943832/1983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
Similar Items
-
Study of cisplatin-vinblastine plus amifostine in patients with locally advanced or metastatic non-small cell lung cancer
by: Thongprasert S., et al.
Published: (2014) -
Preliminary study of efficacy of intravenous cisplatin plus oral etoposide in small cell lung cancer
by: Chewaskulyong B., et al.
Published: (2014) -
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
by: Chang J.W.-C., et al.
Published: (2014) -
An indirect comparison of bevacizumab plus cisplatin-gemcitabine and cisplatin plus pemetrexed treatment for patients with advanced first-line non-squamous non-small cell lung cancer in East Asia
by: John Wen Cheng Chang, et al.
Published: (2018) -
Phase II study of cisplatin combined to irinotecan administered alternatingly with docetaxel in advanced non-small cell lung cancer
by: Charoentum C., et al.
Published: (2014)